Should intravenous immunoglobulin G be first-line treatment for acute thrombotic thrombocytopenic purpura? Case report and review of the literature.

Raniele, D P; Opsahl, J A; Kjellstrand, C M

Raniele, D P; Opsahl, J A; Kjellstrand, C M.

Affiliation

Raniele DP; Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN.

Am J Kidney Dis ; 18(2): 264-8, 1991 Aug.

Article in En | MEDLINE | ID: mdl-1867184

Subject(s)

Immunoglobulin G/therapeutic use; Purpura, Thrombotic Thrombocytopenic/therapy; Acute Disease; Adult; Combined Modality Therapy; Costs and Cost Analysis; Humans; Immunoglobulin G/administration & dosage; Infusions, Intravenous; Male; Plasmapheresis/economics; Purpura, Thrombotic Thrombocytopenic/economics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Immunoglobulin G Type of study: Clinical_trials / Health_economic_evaluation Limits: Adult / Humans / Male Language: En Journal: Am J Kidney Dis Year: 1991 Document type: Article Affiliation country: Mongolia Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links